Back
Allogene Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
70
ALLO
Allogene Therapeutics, Inc.
Last Price:
$2.07
Seasonality Move:
-11.41%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALLO is experiencing slight selling pressure.
Allogene Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.88 | Buy |
| 20-day SMA: | 1.76 | Buy |
| 50-day SMA: | 1.6 | Buy |
| 200-day SMA: | 1.32 | Buy |
| 8-day EMA: | 1.96 | Buy |
| 20-day EMA: | 1.8 | Buy |
| 50-day EMA: | 1.63 | Buy |
| 200-day EMA: | 1.52 | Buy |
Allogene Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 64.8 | Buy |
| Chaikin Money Flow: | -2450225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.53 - 1.93) | Buy |
| Bollinger Bands (100): | (1.2 - 1.66) | Buy |
Allogene Therapeutics, Inc. Technical Analysis
| Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Allogene Therapeutics, Inc. Stock
Is Allogene Therapeutics, Inc. Stock a Buy?
-
Allogene Therapeutics, Inc. share price is 2.13 while ALLO 8-day simple moving average is 1.88, which is a Buy signal.
-
The stock price of ALLO is 2.13 while Allogene Therapeutics, Inc. 20-day SMA is 1.76, which makes it a Buy.
-
Allogene Therapeutics, Inc. 50-day simple moving average is 1.60 while ALLO share price is 2.13, making it a Buy technically.
-
ALLO stock price is 2.13 and Allogene Therapeutics, Inc. 200-day simple moving average is 1.32, creating a Buy signal.
ALLO Technical Analysis vs Fundamental Analysis
Buy
70
Allogene Therapeutics, Inc. (ALLO)
is a Buy
Is Allogene Therapeutics, Inc. a Buy or a Sell?
-
Allogene Therapeutics, Inc. stock is rated a BuyThe current Allogene Therapeutics, Inc. [ALLO] share price is $2.13. The Score for ALLO is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Allogene Therapeutics, Inc. Stock Info
Market Cap:
478.7M
Price in USD:
2.13
Share Volume:
5.9M
Allogene Therapeutics, Inc. 52-Week Range
52-Week High:
2.64
52-Week Low:
0.86
Buy
70
Allogene Therapeutics, Inc. (ALLO)
is a Buy
Allogene Therapeutics, Inc. Share Price Forecast
-
What is the Allogene Therapeutics, Inc. stock price today?The Allogene Therapeutics, Inc. stock price is 2.13 USD today.
-
Will ALLO stock go up or go down?Allogene Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Allogene Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics, Inc. is not overvalued.
Is Allogene Therapeutics, Inc. Stock a Buy?
-
Allogene Therapeutics, Inc. share price is 2.13 while ALLO 8-day exponential moving average is 1.96, which is a Buy signal.
-
The stock price of ALLO is 2.13 while Allogene Therapeutics, Inc. 20-day EMA is 1.80, which makes it a Buy.
-
Allogene Therapeutics, Inc. 50-day exponential moving average is 1.63 while ALLO share price is 2.13, making it a Buy technically.
-
ALLO stock price is 2.13 and Allogene Therapeutics, Inc. 200-day simple moving average is 1.52, creating a Buy signal.
Fundamental Analysis of Allogene Therapeutics, Inc.
Is Allogene Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.05 per share.
Technical Analysis of Allogene Therapeutics, Inc.
Should I short Allogene Therapeutics, Inc. stock?
-
ALLO Moving Average Covergence Divergence (MACD) indicator is 0.13, suggesting Allogene Therapeutics, Inc. is a Buy
-
Allogene Therapeutics, Inc. Relative Strength Index (RSI) is 64.8, which suggest Allogene Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Allogene Therapeutics, Inc. is (1.53 - 1.93), which suggest Allogene Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Allogene Therapeutics, Inc. is (1.2 - 1.66), which suggest Allogene Therapeutics, Inc. is a Buy
* Allogene Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.